Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pseudomonas Gastrointestinal Tract Infection”

80 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 80 results

Testing effectiveness (Phase 2)Study completedNCT05010577
What this trial is testing

Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection

Who this might be right for
Chronic Pseudomonas Aeruginosa InfectionCystic Fibrosis
BiomX, Inc. 43
Not applicableApproved For MarketingNCT00989807
What this trial is testing

Expanded Access Program for Aztreonam Lysine for Inhalation in Canadian Patients With Cystic Fibrosis

Who this might be right for
Cystic FibrosisPseudomonas Aeruginosa
Gilead Sciences
Not applicableStudy completedNCT01375036
What this trial is testing

Registry to Monitor the Susceptibility to Aztreonam of Pseudomonas Aeruginosa Isolates From Cystic Fibrosis Patients

Who this might be right for
Cystic Fibrosis
Gilead Sciences 510
Large-scale testing (Phase 3)Study completedNCT00104520
What this trial is testing

Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa

Who this might be right for
Cystic Fibrosis
Gilead Sciences 211
Post-approval studies (Phase 4)Ended earlyNCT00333385
What this trial is testing

Continuous Versus Short Infusions of Ceftazidime in Cystic Fibrosis

Who this might be right for
Cystic FibrosisPseudomonas AeruginosaPulmonary Exacerbation
Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche 120
Large-scale testing (Phase 3)Study completedNCT02054156
What this trial is testing

OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Bonnie Ramsey 221
Early research (Phase 1)Study completedNCT00910351
What this trial is testing

Cipro Inhaler for Cystic Fibrosis Children Ages 6-12

Who this might be right for
Pseudomonas Infection
Bayer 19
Large-scale testing (Phase 3)WithdrawnNCT01315691
What this trial is testing

Study to Evaluate Arikace™ in CF Patients With Chronic Infection Due to Pseudomonas Aeruginosa

Who this might be right for
Cystic Fibrosis
Insmed Incorporated
Not applicableUnknownNCT05675592
What this trial is testing

Trikafta/Kaftrio and Pseudomonas Aeruginosa

Who this might be right for
Cystic Fibrosis
Ospedale San Raffaele 20
Testing effectiveness (Phase 2)Study completedNCT00794586
What this trial is testing

Study Evaluating Fosfomycin/Tobramycin for Inhalation in Cystic Fibrosis Patients With Pseudomonas Aeruginosa Lung Infection

Who this might be right for
Cystic Fibrosis
Gilead Sciences 120
Not applicableStudy completedNCT01319253
What this trial is testing

A Comparator Study Evaluating Microbiological Resistance and Effects of Alternating Inhaled Antibiotic Therapies

Who this might be right for
Cystic FibrosisPseudomonas Aeruginosa
Indiana University 27
Large-scale testing (Phase 3)Study completedNCT00391976
What this trial is testing

Efficacy and Safety of 28 or 56 Day Treatment for Pseudomonas Aeruginosa in Children With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Novartis 123
Not applicableStudy completedNCT01651455
What this trial is testing

Retrospective Observational Study to Compare Cystic Fibrosis Patients in Two Decades Before and After 2000

Who this might be right for
Cystic Fibrosis
Chiesi Farmaceutici S.p.A. 92
Not applicableStudy completedNCT01379040
What this trial is testing

Volatile Organic Compounds in Cystic Fibrosis

Who this might be right for
Cystic FibrosisPseudomonas Aeruginosa
Landon Pediatric Foundation 24
Testing effectiveness (Phase 2)Study completedNCT05453578
What this trial is testing

A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa

Who this might be right for
Bacterial Disease CarrierCystic Fibrosis
National Institute of Allergy and Infectious Diseases (NIAID) 72
Not applicableStudy completedNCT00027183
What this trial is testing

Role of Toxins in Lung Infections Caused by Pseudomonas Aeruginosa

Who this might be right for
Pseudomonas InfectionCystic Fibrosis
National Heart, Lung, and Blood Institute (NHLBI) 134
Post-approval studies (Phase 4)Study completedNCT01429259
What this trial is testing

Population Pharmacokinetics of Prolonged Infusion Meropenem in Cystic Fibrosis (CF) Children

Who this might be right for
Cystic FibrosisPneumoniaPseudomonas Aeruginosa Infection
Joseph Kuti 30
Not applicableStudy completedNCT00015756
What this trial is testing

Tissue Collection From People With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
National Heart, Lung, and Blood Institute (NHLBI) 100
Large-scale testing (Phase 3)Study completedNCT01069705
What this trial is testing

Second Open Label Extension to Bridging Study CTBM100C2303

Who this might be right for
Pulmonary InfectionsPseudomonas Aeruginosa
Novartis Pharmaceuticals 49
Testing effectiveness (Phase 2)Study completedNCT00786513
What this trial is testing

Use of a Biofilm Antimicrobial Susceptibility Assay to Guide Antibiotic Therapy

Who this might be right for
Cystic Fibrosis
The Hospital for Sick Children 134
Load More Results